Dexa Group CEO, Ferry A. Soetikno received the Indonesia Most Admired CEO Award 2018 on Friday, December 14, 2018 for the category of Excellent Leadership for Supporting Government Health Programs. The award recognizes Dexa Group’s commitment to support the government’s health programs through the innovation and production of best quality medicines.

The Indonesia Most Admired CEO Award 2018 was presented directly by the Former Minister of Maritime Affairs and Fisheries and Founder of Warta Ekonomi, Fadel Muhammad accompanied by Warta Ekonomi CEO & Chief Editor, Muhamad Ihsan to OGBdexa Sales Director, Tarcisius T. Randy. Also present at the event was Dexa Group Head of Corporate Communications, Sonny Himawan.

Founded in 1969 in Palembang, Dexa Medica’s initial aim was to provide a solution to the scarce supply of medicine in South Sumatera. By 1990, Dexa Medica had evolved to be the first national private pharmaceutical company that participated in producing Logo Generic Drugs (OGB). The company offers high-quality medicines at affordable prices. Currently, Dexa Medica’s medicines are available for patients of the National Health Insurance (JKN) program.

“We are very humbled and grateful to receive this award. I also would like to express our sincerest gratitude to everyone who continues to support PT Dexa Medica. This award acknowledges PT Dexa Medica’s commitment to provide best quality medicines in Indonesia to achieve better health for everyone, everywhere on national, regional and international levels” said Ferry Soetikno.

“To reach all therapeutic classes, we continue to produce new product variants which meet our consistent standards for quality, safety and efficacy,” said Tarcisius. Corporate Communications Dexa Medica